Actively Recruiting
Improvement of Quality of Life Using Preference-Oriented Monitoring and Linkage with Clinical Registry Data in Patients with Lung Cancer
Led by University of Bayreuth · Updated on 2024-12-16
220
Participants Needed
8
Research Sites
25 weeks
Total Duration
On this page
Sponsors
U
University of Bayreuth
Lead Sponsor
U
University of Regensburg
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating whether a preference-oriented quality of life QoL monitoring system with specific diagnostic and therapeutic options can improve the well-being of patients with lung cancer during routine follow-up care. This study builds on successful QoL interventions for breast and colorectal cancer and aims to adapt the system for lung cancer patients in multiple centers. The study uses electronic QoL questionnaires and links patient data with a cancer registry to support analysis. Participants are randomly assigned to one of two groups. The intervention group receives real-time results from an electronic QoL monitoring system based on the EORTC QLQ-C30 and QLQ-LC29 questionnaires, along with access to a multiprofessional network of therapists such as pain therapy, psychotherapy, social support, nutrition counseling, physiotherapy, fitness, respiratory therapy, and palliative care. The control group also completes QoL assessments but neither patients nor their physicians receive the results however, the therapist network is available for both groups. QoL is assessed at study entry and monthly for six months. Throughout the six-month follow-up, participants complete QoL questionnaires at baseline and monthly intervals. Researchers monitor the proportion of patients needing QoL therapy based on a profile with eight dimensions, with a focus on whether the intervention reduces this need after six months. Data collection includes linking clinical information from a cancer registry. The study involves multiple assessments, therapeutic referrals, and ongoing monitoring to evaluate quality of life improvements in lung cancer patients.
CONDITIONS
Brief Title
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary diagnosis of lung cancer (ICD C33/C34, all stages)
- Treatment at one of six specified hospitals
- Diagnosis date within 2 months before study entry
- Provided informed consent
You will not qualify if you...
- No available study clinician for recruitment
- Misclassification of diagnosis (no lung tumor)
- Refusal by coordinating practitioner to participate
- Residence outside defined study region in Bavaria, Germany
- Under 18 years of age
- Pregnancy or breastfeeding
- Unable to complete quality of life questionnaires due to physical, psychological, cognitive, or language reasons
- Patient refuses participation
Research Team
M
Martin Emmert, PhD, Prof.
M
Monika Klinkhammer-Schalke, MD, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here